semaglutide weight loss fda approval Novo Nordisk's weight-loss pill wins FDA approves obesity drug that

Adverse effects such as nausea and digestive issues were more common among participants taking GLP-1 drugs, and data on cardiovascular outcomes, mortality, and quality of life remain uncertain

We thank the Department of Science & Technology (DST), Government of India (DST- FIST: SR/FST/LS-I/2017(C)) for the infrastructure grant

One woman reported paying just $300 per month for her prescription, which originally cost over triple that amount before switching from Ozempic to a generic version

So, whether bacteria or archaea are coming in from the outside, moving backward from the large intestine, or simply overgrowing in place, each of these routes can contribute to the overgrowth in the small intestine that we call SIBO

Avoid high-fat meals and large portions Especially early on when starting GLP-1 medications, it can help to avoid large or heavy meals